LYTIR

Insider · SEC Form 4 · President & CEO

Barry Richard

In the 12 months to Nov 19, 2026, on the open market: bought $563K of FLNA. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $563K in total; Insider sales: $0 in total.Sep: Insider purchases $356KNov: Insider purchases $207KDecJanFebMarAprMayJunJulAugSepOctNov$356K
Insider purchases above the line: $563KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. FLNABought: FILANA THERAPEUTICS, INC. Nov 16, 2026 440,206 shares filed Nov 18, 2026 1,778,170 shares held indirectly after, as filed filing $207K
  2. FLNABought: FILANA THERAPEUTICS, INC. Sep 30, 2026 100,000 shares filed Oct 1, 2026 1,337,964 shares held indirectly after, as filed filing $92K
  3. FLNABought: FILANA THERAPEUTICS, INC. Sep 29, 2026 206,813 shares filed Oct 1, 2026 1,237,964 shares held indirectly after, as filed filing $186K
  4. FLNABought: FILANA THERAPEUTICS, INC. Sep 28, 2026 93,091 shares filed Sep 30, 2026 1,031,151 shares held indirectly after, as filed filing $78K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.